Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia von Seymour, John F, Kipps, Thomas J, Eichhorst, Barbara, Hillmen, Peter, D’Rozario, James, Assouline, Sarit, Owen, Carolyn, Gerecitano, John, Robak, Tadeusz, De la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Humerickhouse, Rod, Punnoose, Elizabeth A, Li, Yan, Boyer, Michelle, Humphrey, Kathryn, Mobasher, Mehrdad, Kater, Arnon P

Volltext

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL von Flinn, Ian W., Hillmen, Peter, Montillo, Marco, Nagy, Zsolt, Illés, Árpád, Etienne, Gabriel, Delgado, Julio, Kuss, Bryone J., Tam, Constantine S., Gasztonyi, Zoltán, Offner, Fritz, Lunin, Scott, Bosch, Francesco, Davids, Matthew S., Lamanna, Nicole, Jaeger, Ulrich, Ghia, Paolo, Cymbalista, Florence, Portell, Craig A., Skarbnik, Alan P., Cashen, Amanda F., Weaver, David T., Kelly, Virginia M., Turnbull, Barry, Stilgenbauer, Stephan

Volltext

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study von Kater, Arnon P, Wu, Jenny Qun, Kipps, Thomas, Eichhorst, Barbara, Hillmen, Peter, D'Rozario, James, Assouline, Sarit, Owen, Carolyn, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Dubois, Julie, Eldering, Eric, Mellink, Clemens, Van Der Kevie-Kersemaekers, Anne-Marie, Kim, Su Young, Chyla, Brenda, Punnoose, Elizabeth, Bolen, Christopher R, Assaf, Zoe June, Jiang, Yanwen, Wang, Jue, Lefebure, Marcus, Boyer, Michelle, Humphrey, Kathryn, Seymour, John F

Volltext

Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab von Byrd, John C., Hillmen, Peter, O'Brien, Susan, Barrientos, Jacqueline C., Reddy, Nishitha M., Coutre, Steven, Tam, Constantine S., Mulligan, Stephen P., Jaeger, Ulrich, Barr, Paul M., Furman, Richard R., Kipps, Thomas J., Thornton, Patrick, Moreno, Carol, Montillo, Marco, Pagel, John M., Burger, Jan A., Woyach, Jennifer A., Dai, Sandra, Vezan, Remus, James, Danelle F., Brown, Jennifer R.

Volltext

Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab von Seymour, John F., Kipps, Thomas J., Eichhorst, Barbara F., D'Rozario, James, Owen, Carolyn J., Assouline, Sarit, Lamanna, Nicole, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Mellink, Clemens, Chyla, Brenda, Panchal, Anesh, Lu, Tong, Wu, Jenny Q., Jiang, Yanwen, Lefebure, Marcus, Boyer, Michelle, Kater, Arnon P.

Volltext

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials von Brown, Jennifer R, Moslehi, Javid, O'Brien, Susan, Ghia, Paolo, Hillmen, Peter, Cymbalista, Florence, Shanafelt, Tait D, Fraser, Graeme, Rule, Simon, Kipps, Thomas J, Coutre, Steven, Dilhuydy, Marie-Sarah, Cramer, Paula, Tedeschi, Alessandra, Jaeger, Ulrich, Dreyling, Martin, Byrd, John C, Howes, Angela, Todd, Michael, Vermeulen, Jessica, James, Danelle F, Clow, Fong, Styles, Lori, Valentino, Rudy, Wildgust, Mark, Mahler, Michelle, Burger, Jan A

Volltext

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThe... von Pfreundschuh, Michael, Prof, Kuhnt, Evelyn, MSc, Trümper, Lorenz, Prof, Österborg, Anders, Prof, Trneny, Marek, Prof, Shepherd, Lois, MD, Gill, Devinder S, MD, Walewski, Jan, MD, Pettengell, Ruth, Prof, Jaeger, Ulrich, Prof, Zinzani, Pier-Luigi, MD, Shpilberg, Ofer, Prof, Kvaloy, Stein, Prof, de Nully Brown, Peter, MD, Stahel, Rolf, MD, Milpied, Noel, Prof, López-Guillermo, Armando, MD, Poeschel, Viola, MD, Grass, Sandra, MD, Loeffler, Markus, Prof, Murawski, Niels, MD

Volltext

Short-Term Psychodynamic Psychotherapy and Cognitive-Behavioral Therapy in Generalized Anxiety Disorder: A Randomized, Controlled Trial von Leichsenring, Falk, Salzer, Simone, Jaeger, Ulrich, Kächele, Horst, Kreische, Reinhard, Leweke, Frank, Rüger, Ulrich, Winkelbach, Christel, Leibing, Eric

Volltext

Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study i... von Mayerhoefer, Marius E, Karanikas, Georgios, Kletter, Kurt, Prosch, Helmut, Kiesewetter, Barbara, Skrabs, Cathrin, Porpaczy, Edit, Weber, Michael, Knogler, Thomas, Sillaber, Christian, Jaeger, Ulrich, Simonitsch-Klupp, Ingrid, Ubl, Philipp, Müllauer, Leonhard, Dolak, Werner, Lukas, Julius, Raderer, Markus

Volltext

Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients von MAYERHOEFER, Marius E, KARANIKAS, Georgios, HOFFMANN, Martha, SILLABER, Christian, JAEGER, Ulrich, MÜLLAUER, Leonhard, SIMONITSCH-KLUPP, Ingrid, DOLAK, Werner, GAIGER, Alexander, UBL, Philipp, LUKAS, Julius, RADERER, Markus, KLETTER, Kurt, PROSCH, Helmut, KIESEWETTER, Barbara, SKRABS, Cathrin, PORPACZY, Edit, WEBER, Michael, PINKER-DOMENIG, Katja, BERZACZY, Dominik

Volltext

Correlation between glycolytic activity on [18F]‐FDG‐PET and cell density on diffusion‐weighted MRI in lymphoma at staging von Giraudo, Chiara, Karanikas, Georgios, Weber, Michael, Raderer, Markus, Jaeger, Ulrich, Simonitsch‐Klupp, Ingrid, Mayerhoefer, Marius E.

Volltext

Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial von Nowakowski, Grzegorz S., Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas S., Patel, Krish, Jäger, Ulrich, Manges, Robert F., Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh, Brown, Peter, Jørgensen, Judit Meszaros, Cunningham, David, Dell’Aringa, Justine, Fox, Brian, Rubio, Neus Domper, Kilavuz, Nurgul, Casadebaig, Marie-Laure, Manzke, Oliver, Munoz, Javier

Volltext

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial von Jaeger, Ulrich, Trneny, Marek, Melzer, Helen, Praxmarer, Michael, Nawarawong, Weerasak, Ben Yehuda, Dina, Goldstein, David, Mihaljevic, Bilijana, Ilhan, Osman, Ballova, Veronika, Hedenus, Michael, Hsiao, Liang-Tsai, Au, Wing-Yan, Burgstaller, Sonja, Weidinger, Gerhard, Keil, Felix, Dittrich, Christian, Skrabs, Cathrin, Klingler, Anton, Chott, Andreas, Fridrik, Michael A, Greil, Richard

Volltext

PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas von Laimer, Daniela, Dolznig, Helmut, Kollmann, Karoline, Vesely, Paul W, Schlederer, Michaela, Merkel, Olaf, Schiefer, Ana-Iris, Hassler, Melanie R, Heider, Susi, Amenitsch, Lena, Thallinger, Christiane, Staber, Philipp B, Simonitsch-Klupp, Ingrid, Artaker, Matthias, Lagger, Sabine, Turner, Suzanne D, Pileri, Stefano, Piccaluga, Pier Paolo, Valent, Peter, Messana, Katia, Landra, Indira, Weichhart, Thomas, Knapp, Sylvia, Shehata, Medhat, Todaro, Maria, Sexl, Veronika, Höfler, Gerald, Piva, Roberto, Medico, Enzo, Ruggeri, Bruce A, Cheng, Mangeng, Eferl, Robert, Egger, Gerda, Penninger, Josef M, Jaeger, Ulrich, Moriggl, Richard, Inghirami, Giorgio, Kenner, Lukas

Volltext

Hot therapy for cold agglutinin disease von Jaeger, Ulrich

Volltext

Health Economic Aspects of Chimeric Antigen Receptor T‐cell Therapies for Hematological Cancers: Present and Future von Heine, Renaud, Thielen, Frederick W., Koopmanschap, Marc, Kersten, Marie José, Einsele, Hermann, Jaeger, Ulrich, Sonneveld, Pieter, Sierra, Jorge, Smand, Carin, Uyl‐de Groot, Carin A.

Volltext

A decade of collaboration in medicines regulation: healthcare professionals engaging with the European Medicines Agency von Silva, Ivana, Gabrielli, Giulia, Garcia Burgos, Juan, Moulon, Isabelle, Calvo Rojas, Gonzalo, Jaeger, Ulrich, Giuliani, Rosa

Volltext

Response to comment by P. Vassilakopoulos and colleagues von Jaeger, Ulrich, Praxmarer, Michael, Greil, Richard

Volltext

Mechanical power density, spontaneous breathing indexes, and prolonged weaning failure: a prospective cohort study von Ghiani, Alessandro, Walcher, Swenja, Lutfi, Azal, Paderewska, Joanna, Jaeger, Simon Ulrich, Kneidinger, Nikolaus, Stecher, Stephanie Susanne, Trudzinski, Franziska Christina, Neurohr, Claus

Volltext

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without ri... von Pfreundschuh, Michael, Prof, Ho, Anthony D, MD, Cavallin-Stahl, Eva, MD, Wolf, Max, Prof, Pettengell, Ruth, Prof, Vasova, Ingrid, MD, Belch, Andrew, MD, Walewski, Jan, MD, Zinzani, Pier-Luigi, MD, Mingrone, Walter, MD, Kvaloy, Stein, MD, Shpilberg, Ofer, Prof, Jaeger, Ulrich, Prof, Hansen, Mads, Prof, Corrado, Claudia, MD, Scheliga, Adriana, MD, Loeffler, Markus, Prof, Kuhnt, Evelyn, Dipl Math

Volltext